Ridgeback Capital Investments
Investor profile
Venture capital
Ridgeback Capital Investments has backed 1 European tech company across 1 funding round in 2021, joining rounds totalling €138M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2021
1 yr
Total round €
€138M
sum of rounds joined
Deals by year
distinct rounds / yearRidgeback Capital Investments — deals by year — interactive chart.
Data table
| Ridgeback Capital Investments — deals by year | |
|---|---|
| 2021 | 1 |
Top sectors
by dealsRidgeback Capital Investments — top sectors — interactive chart.
Data table
| Ridgeback Capital Investments — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsRidgeback Capital Investments — stages — interactive chart.
Data table
| Ridgeback Capital Investments — stages | |
|---|---|
| Series B | 1 |
Countries
by dealsRidgeback Capital Investments — countries — interactive chart.
Data table
| Ridgeback Capital Investments — countries | |
|---|---|
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |